Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteinterceptpharma.com
CategoryBioTech
Phone646-747-1000
Emailinfo@interceptpha...
Employees
Founded2002

Offices

New York, USA
18 Desbrosses Street
New York, NY, 10013
USA

People

Founder ,CEO & Board Member
CFO
Board Member
Board Member
Board Member
Board Member
Board Member
Board Member
Show All People

Funding

TOTAL $55M
FUNDING TOTAL $55M
Series B, 1/2010
$25M
Series C, 8/2012
OrbiMed Advisors
$30M

Tags

Intercept Pharmaceuticals

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, a FXR modulating agent that treats patients with chronic autoimmune liver diseases. The company’s drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases. Intercept Pharmaceuticals, Inc. was founded in 2002 and is based in New York, New York.

Recent Milestones

Videos

Screenshots

Intercept Pharmaceuticals screenshot
Above: Home Page
Uploaded: 1/26/10

Sources

  1. Intercept Pharmaceuticals Raises $25M Series B Financing (finsmes.com) [edit]
  2. Intercept Pharmaceuticals Completes $30M Series C Financing (finsmes.com) [edit]
Edit This Page
Last Edited 12/5/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy